[Prolonged remission in subacute myeloid leukemia achieved by consecutive administration of 6-mercaptopurine and myleran].
D002066:Busulfan / Q000627:therapeutic use*; D006801:Humans; D007938:Leukemia; D007951:Leukemia, Myeloid / Q000628:therapy*; D054438:Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; D015122:Mercaptopurine / Q000627:therapeutic use*
D015122:Mercaptopurine; D002066:Busulfan
BUSULFAN/therapeutic use; LEUKEMIA, MYELOCYTIC/therapy; MERCAPTOPURINE/therapeutic use
Dlitel'naia remissiia pri podostrom mieloleikoze, dostignutaia posledovatel'nym primeneniem 6-merkaptopurina i milerana.